Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study Of Depsipeptide In Patients With Relapsed Or Refractory Ovarian Carcinoma

NCT00085527 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT00085527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00085527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study Of Depsipeptide In Patients With Relapsed Or Refractory Ovarian Carcinoma
Lead sponsor
University of Chicago
Phase
Phase 2
Overall status
Withdrawn
Start date
May 31, 2005
Completion date
September 30, 2005
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer